Toward non-parametric and clinically meaningful moderators and mediators

Area of Science:

• Biostatistics
• Clinical Trial Methodology
• Epidemiology

Background:

• Randomized clinical trials (RCTs) and risk research increasingly require understanding treatment effects beyond overall significance.
• Identifying *who* (moderators), *how* (mediators), and *how much* (effect sizes) treatments impact outcomes is crucial for clinical significance.
• Traditional methods using statistical significance in linear models often yield inconsistent and hard-to-interpret results regarding clinical impact.

Purpose of the Study:

• To introduce novel non-parametric methods for assessing moderators and mediators in clinical research.
• To facilitate the consideration of clinical significance in the analysis of treatment effects.
• To address limitations of traditional statistical significance-based approaches.

Main Methods:

• Development and introduction of non-parametric statistical methods.
• Focus on binary moderators and mediators.
• Exploration of generalizable methods for broader application.

Main Results:

• Proposed non-parametric methods are designed to directly address clinical significance.
• These methods offer an alternative to traditional significance testing for moderators and mediators.
• The study initiates a discussion on the requirements for generalizable non-parametric approaches.

Conclusions:

• Non-parametric methods provide a more interpretable framework for evaluating clinical significance in RCTs.
• The introduced methods enhance the understanding of treatment effects by focusing on moderators and mediators.
• Further development is needed to generalize these approaches for comprehensive clinical research analysis.